Omnisystem KRX:057540KOSDAQ
옴니시스템 · Korean news coverage and regulatory filings, organized.
Articles, 24h1
Articles, 7 days1
DART filings, 7 days1
Articles tracked2since Sep 11
In Q2 2026, Omnisystem reported revenue of ₩24.2bn, down 14.0% year on year, and operating profit of ₩77m. Omnisystem (옴니시스템) appeared in 1 Korean news article and 1 DART filing over the past seven days. Coverage peaked on Oct 8 with 1 article. The most common catalyst was risk & warnings (1). It was most often mentioned alongside BioSmart.
Filing signals Turnaround Insider selling Screener
Omnisystem quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩24.2bn | -14.0% | ₩77m margin 0.3% | ₩275m |
| Q1 2026 | ₩18.4bn | -32.6% | −₩289m margin −1.6% | ₩969m |
| Q4 2025 derived | ₩24.3bn | -24.7% | ₩1.4bn margin 5.8% | ₩1.3bn |
| Q3 2025 | ₩19.4bn | -31.3% | −₩76m margin −0.4% | −₩739m |
| Q2 2025 | ₩28.2bn | +10.0% | −₩65m margin −0.2% | −₩190m |
| Q1 2025 | ₩27.2bn | +18.5% | −₩259m margin −1.0% | −₩478m |
| Q4 2024 derived | ₩32.3bn | +29.2% | ₩3.2bn margin 9.9% | ₩4.3bn |
| Q3 2024 | ₩28.2bn | +45.3% | ₩332m margin 1.2% | −₩495m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Omnisystem top stories 2 weeks, by number of outlets
- 1
- 2